A procedure for extraction of heroin and metabolites for gas chromatography-mass spectrometry (GC-MS) analysis of meconium specimens that would allow detection of these analytes at low levels was needed. Solid-phase extraction (SPE) cartridges were therefore evaluated for their effectiveness in sample preparation. Four different types of commercially available extraction cartridges were used. Heroin, 6-monoacetylmorphine (6-MAM), morphine, and codeine were extracted from meconium samples using these SPE cartridges and then simultaneously analyzed using GC-MS. In each case, the extraction efficiency, linearity range, limit of detection (LOD), limit of quantitation (LOQ), between-run precision, and within-run precision were determined. Although satisfactory results were obtained with the four different types of SPE cartridges, best overall performance was observed using Clean Screen | columns following the procedures outlined here. LODs as low as 20 ng/g for codeine, 10 ng/g for morphine, and 2.5 ng/g for 6-MAM were obtained, and LOQs as low as 20 ng/g for codeine, 10 ng/g for morphine, and 5 ng/g for 6-MAM were obtained. In all cases linearities were observed (r = > 0.99) for codeine, morphine, and 6-MAM over a wide concentration range (100-2000, 100-2000, and 5-100, respectively). At 50 ng/g codeine and morphine and 10 ng/g 6-MAM, the precision of analysis using these cartridges showed coefficients of variation ranging from 4.75% to 15.5%.
Introduction
Testing of meconium for the presence of metabolites of drugs of abuse has become the most widely accepted alternative to urine analysis for the purpose of detecting prenatal exposure to these drugs (1) . The choice of meconium as an analytical sample has several advantages: meconium specimens are easier to collect (2) , contain more drug metabolites (3) , and extend the window of drug detection to approximately the last 20 weeks of gestation (4, 5) . However, meconium samples are more difficult to analyze, and additional processing steps are required to disrupt the tissues and to extract the analytes from this nonuniform matrix (6--8) .
Review of the literature shows several reports dealing with the analysis of meconium specimens for opiates using different immunoassays such as radioimmunoassay (RIA) (3, 9) , TDx (10, 11) , and EMIT (6, 12) . Confirmation for the presence of morphine was either lacking (3, 9) or was carried out by another technique such as thin-layer chromatography (TLC) (6) , highperformance liquid chromatography (HPLC) (11), or gas chromatography-mass spectrometry (GC-MS) (10, 12) . However, in all of these reports, the confirmation focused on the analysis of total morphine only. Therefore, there was, in fact, no distinction made between samples found positive for morphine as the result of morphine versus codeine versus heroin ingestion.
The aim of this work was to develop a procedure that allows for the determination of heroin metabolites in meconium samples.
from Sigma-Aldrich Co. (St. Louis, MO). Heroin-d3 was purchased from Lipomed (Cambridge, MA). Detectabuse TM extraction columns (gravity series, type GV-65) were obtained from Biochemical Diagnostics, Inc (Edgewood, NY). Clean Screen extraction columns (ZCDAU020) were purchased from Worldwide Monitoring (trademark of United Chemical Technologies, Inc., Bristol, PA). Bond Elut Certify | columns (1210-2051) were purchased from Varian Corp. (Harbor City, CA), and SPEC | columns, Spec.Plus.3ML.MP3, were purchased from Spec (Division of Ansys, Inc., Irvine, CA). The columns were processed using a VacElut vacuum manifold purchased from Varian Corp. All other chemicals and solvents were ACS or HPLC grade.
Instrumentation
A Hewlett-Packard (HP) 5890A GC and a 5970A HewlettPackard (HP) mass selective detector were used. The GC-MS was fitted with a DB-1 column (15 m x 0.25-mm i.d., 0.25-1Jm film thickness). For those specimens where interference was observed with the heroin ions, a DB-5 MS column (25 m x 0.2-mm i.d., 0.33-pro film thickness) was used.
Procedures
Extraction procedure. One gram of meconium was weighed into a 16 x 100-ram culture tube. Calibrators were prepared by spiking blank meconium with the appropriate amounts of stan- dard opiates solution to achieve the desired concentrations. All calibrators, controls, and unknown specimen tubes were spiked with 100 IJL of internal standard opiates solution (1 IJg/mL) followed by the addition of 3 mL methanol. Tissues were disrupted until complete homogenization using a tissue tearor (model 985-370, Biospec Products, Inc.) or an ultrasonic disruptor (Tekmar model TM600 set for 30-s cycles). The tubes were centrifuged at 5000 rpm for 15 rain, and the supernatant from each was immediately transferred to another properly labeled 16 x 100-mm tube. The solvent was evaporated under nitrogen at a temperature of approximately 40~ The residue was dissolved in the appropriate buffer and loaded onto a preconditioned SPE column. The column conditioning, sample loading, washing, and analyte elution steps are summarized in Table I .
Hydrolysis procedure. For the determination of morphine glucuronide, enzymatic hydrolysis with ~-glucuronidase (type IX-A, from E. coli) was employed. A stock solution (2500 units/100 IJL) was prepared by reconstituting with the appropriate volume of 0.1M phosphate buffer (pH 6.8). For enzymatic hydrolysis of meconium extracts, the residue obtained after evaporation of the methanol extract was dissolved in 2 mL phosphate buffer (pH 6.8), 100 IJL of enzyme solution was added, and the mixture was incubated at 37~ for 3 h. The appropriate buffer for each SPE column was then added, the pH of the sample was adjusted with 0.1N KOH or 0.1N HCI to the required pH of the cartridge, and extraction was continued as described.
Derivatization
The eluates containing the extracted opiates were concentrated by evaporation under nitrogen to approximately 0.5 mL, then transferred to a GC vial, and evaporation was continued to dryness. The residue was derivatized with 50 IJL BSTFA at 70~ for 30 rain.
GC-MS analysis
The chromatographic operating conditions for the DB-1 column were as follows: splitless injection, column initial temperature was 120~ held for i rain after injection, then raised to 250~ at 30~ and held there for 4 min. The electron multiplier voltage was set at 200 mV above the standard autotune value. The data were acquired in the selected ion monitoring (SIM) mode. The retention time, quantitation ion, and qualifier ions for each analyte are shown in Table II . The GC operating conditions for the DB-5 column were as follows: splitless injection, column initial temperature was 200~ held for 2 rain after injection, then raised to 260~ at 20~ and held there for 10 min. The electron multiplier voltage was set at 200 mV above the standard autotune value, and the data were acquired in the selected ion monitoring (SIM) mode.
Linearity, limit of detection (LOD), and limit of quantitation (LOQ)
Aliquot volumes of standard opiates solution (10 IJg/mL of codeine and morphine and 0.5 l~g/mL of 6-monoacetylmorphine and heroin) were accurately added to 1 g of drug-free meconium to obtain a concentration range of 10-2000 ng/g of codeine and morphine and 0.5-100 ng/g of 6-MAM and heroin. The internal standards solution (100 I~L/tube) was added to all the samples. The spiked meconium samples were extracted and analyzed following the previously described procedures, and the results obtained were used to determine the linearity range, LOD, and LOQ for each procedure (Table III) .
Reproducibility
The between-and within-run precisions were determined by analyzing meconium samples spiked with 50 ng/g of codeine and morphine and 10 ng/g of 6-MAM and heroin in the presence of 100-ng/g of internal standards (Table III) .
Extraction efficiency
Drug-free meconium was spiked with standard solutions of codeine, morphine, 6-MAM, and heroin to a concentration of 100 ng/g of each analyte. The spiked samples were extracted as described under each SPE column except that the internal standards were added after extraction and prior to derivatization. The area ratios obtained were compared to those obtained from spiked samples (100 ng/g) analyzed in the usual manner to calculate the extraction efficiency (Table III) .
Results and Discussion
Meconium, the first fecal matter passed by the neonate, is a complex matrix containing mainly water, proteins, lipids, mucopolysaccharides, and other characterized and uncharacterized components (7, 13) . Therefore, the analysis of such a matrix requires more efficient cleaning and extraction techniques than other biological specimens such as urine or plasma. For this purpose, four commercially available SPE cartridges were evaluated, and the data obtained were compared to determine the Time Time Figure 1 . Total ion chromatograms of the TMS derivatives of codeine (peak 1), morphine (peak 2), 6-MAM (peak 3), and heroin (peak 4) along with their internal standards, extracted from meconium samples using Detectabuse columns (A), Clean Screen columns (B), Bond Elut Certify columns (C), and SPEC columns (D).
suitability of each type for the analysis of meconium specimens for heroin metabolites. The extraction procedure used in each case was adapted from the method supplied by the manufacturer for the extraction of one or more of these metabolites from various other biological specimens. Biochemical Diagnostics, Varian, and Ansys had established methods for the analysis of codeine and morphine in urine samples, and United Chemical Technologies had a method for the analysis of 6-MAM in meconium. An initial extraction step of the analytes from meconium comprising tissue disruption with 3 mL methanol, centrifugation, and evaporation of the supematant was done in all cases. This was followed by sample application to the preconditioned column, washing, drying, and analyte elution as recommended by each manufacturer (Table I ). Figure 1 shows the total ion chromatograms of the TMS derivatives of codeine, morphine, 6-MAM, and heroin extracted from meconium samples using the four SPE cartridges under evaluation.
The enzymatic hydrolysis of morphine glucuronide was studied. The addition of 2500 units of [~-glucuronidase enzyme from E. coli to 1 g meconium in the presence of phosphate buffer (pH 6.8), followed by incubation for 3 h at 37~ resuited in hydrolysis efficiency of about 50%. Decreasing incubation time to 1 h was not sufficient to hydrolyze morphine glucuronide, and increasing the incubation time to 24 h or increasing the enzyme concentration to 5000 units did not significantly improve the hydrolysis efficiency. In all cases, this hydrolysis step did not affect the cleanliness or the recovery of other analytes. Therefore, for the sake of simplicity, and because Becker et al. (14) reported that morphine in meconium was not significantly glucuronide bound, this hydrolysis step was not incorporated into the routine analysis.
Comparing the different steps required by each type of SPE column for the extraction of heroin metabolites (Table I) , one can conclude that the procedures used with DETECTABUSE columns and SPEC columns are simpler and require reduced volumes of solvents for the conditioning, washing, and elution steps. This means significant time and reagent savings, which are reflected as lower costs and less environmental pollution. DETECTABUSE columns offer the following advantages: cleaner extracts and consequently cleaner chromatograms, vacuum is only needed in the drying step, eluates pass directly to waste or into collection tubes which eliminates carryover contamination, and a lower LOQ for morphine than other cartridges. The disadvantages of DETECTABUSE columns are the lower extraction efficiency for morphine and the presence of an interfering substance in some meconium samples at the retention time of morphine on the DB-5 column that resulted in a retention time shift of the morphine peak and decreased its peak width. Several trials were done to overcome this problem, including (1) initial extraction of meconium samples using acetonitrile/methanol (9:1); (2) addition of a preliminary liquid-liquid extraction step, using ethyl acetate, hexane, or ethyl acetate/hexane (1:1), from acidic solution; (3) increasing the volume of washing solution to 2 mL hexane/ethyl acetate (1:1), containing 1% HE1; (4) using 1 mL Within-run precision ethyl acetate containing 1% HCl as washing solution; (5) using 5 mL dilute phosphate buffer as washing solution and I mL nbutyl chloride/acetonitrile (7:3) as elution solvent; (6) elution of the analytes using dichloromethane/isopropyl alcohol (85:15); and (7) treating the sample with sodium periodate. However, all of these trials did not improve the results. This problem does not exist on the DB-1 column, which was mainly used throughout this work.
SPEC columns have a higher extraction efficiency for morphine and 6-MAM, but the LOD and LOQ are higher for morphine and the same for 6-MAM because at lower concentrations the ion ratios are out of the acceptable range. It should be noted that in the case of 6-MAM, only the ion ratio 340/399 is monitored; the ion ratio 287/399 is usually not consistent with the calibrators. Attempts to increase the cleanliness of the extracts by using the high capacity discs (SPEC.PIus.10ML.MP3 columns) were unsuccessful.
Clean Screen columns, Bond Elut Certify columns, and SPEC columns require a vacuum manifold equipped with a vacuum gauge and a flow controller for sample processing. The functioning of these components must be regularly monitored to achieve the desired flow rates throughout the different steps of extraction.
The procedure supplied by United Chemical Technologies for the analysis of 6-MAM in meconium specimens using Clean Screen columns involved initial extraction of the analytes from meconium with 2 mL methanol and 100 IJL isopropyl alcohol. The procedure was repeated several times with and without the addition of isopropyl alcohol, and no difference in the results was observed. Therefore, this addition of isopropyl alcohol was eliminated. Clean Screen columns have the advantage of providing the lowest LOQ for 6-MAM, which is important because 6-MAM is the marker for heroin use, but again, only one qualifier ion, the 340 ion, is used.
The eluate obtained from Bond Elut Certify columns was yellow in color and contained suspended particles after evaporation and derivatization with BSTFA, which might contaminate the GC column and affect its lifetime. Although the LOD and LOQ were relatively higher, the between-run precision, within-run precision, and extraction efficiency were satisfactory.
Quantitation of heroin was not successful in all cases using the DB-1 column, but when it was present, one could always see the corresponding peaks, especially with the DETECTABUSE columns and the Clean Screen columns. Reanalyzing these samples with DB-5 columns provided better results.
The practical application of this work was achieved by analyzing 10 meconium samples previously screened by EIA and analyzed by GC-MS following a liquid-liquid extraction method (15) . Nine of these samples screened positive for opiates, and the confirmation of the results by GC-MS following liquid-liquid extraction showed the presence of morphine and codeine. These nine samples were chosen because they contained high concentrations of morphine and low concentrations of codeine, suggesting a profile for heroin use; however, 6-MAM was not identified in eight of those samples because the LOD at that time was 50 ng/g. Sample number 10 screened negative, and, therefore, was used as a negative control. DE-TECTABUSE columns were used for the extraction of the samples. The results obtained are shown in Table IV . For the analysis of 6-MAM in meconium, SPE methods were advantageous over liquid-liquid extraction methods because they allowed the detection of 6-MAM in eight samples previously reported negative (below the LOD) for this metabolite. For the analysis of codeine and morphine, although the specimens had been in storage for five years at -20~ there was a good correlation between the results of the current analysis using the SPE method and the results of the previous liquid-liquid extraction method with correlation coefficients of 0.9621 and 0.7398 for codeine and morphine, respectively. The lower r value for morphine could be due to the difference in the age or the lack of homogeniety of the samples. Heroin itself was not detected in any of the specimens analyzed.
Conclusions
Although the four types of SPE cartridges studied can be used for the analysis of heroin metabolites in meconium specimens, Clean Screen cartridges showed better overall performance. They provided cleaner chromatograms and thus enhanced peak-to-noise ratio. For the detection of 6-MAM, a specific marker for heroin ingestion, Clean Screen cartridges offered the lowest LOD (2.5 ng/g) and LOQ (5 ng/g).
